Inhibition of pyocyanin-potentiated IL-8 release by steroids in bronchial epithelial cells

References 

1. Pitt TL. Biology of Pseudomonas aeruginosa in relation to pulmonary infection in cystic fibrosis. J Roy Soc Med. 1986;
2. Ho PL, Chan KN, Ip MS, et al. The effect of Pseduomonas aeruginosa infection on clinical parameters in steady-state bronchiectasis. Chest. 1998;
3. Wilson R, Sykes DA, Watson D, et al. Measurement of Pseudomonas aeruginosa phenazine pigments in sputum and assessment of their contribution to sputum sol toxicity for respiratory epithelium. Infect Immun. 1988;
4. Denning GM, Wollenweber LA, Railsback MA, et al. Pseudomonas aeruginosa pyocyanin increases interleukin-8 expression by human airway epithelial cells. Infect Immun. 1998;
5. Belperio JA, Keane MP, Arenberg DA, et al. CXC chemokines in angiogenesis. J Leucoc Biol. 2000;
6. Mul FP, Zuurbier AE, Janssen H, et al. Sequential migration of neutrophils across monolayers of endothelial and epithelial cells. J Leucoc Biol. 2000;
7. Mukaida N. Interleukin-8: an expanding universe beyond neutrophil chemotaxis and activation. Int J Haematol. 2000;
8. Blackwell TS, Christman JW. The role of nuclear factor-kappa B in cytokine gene regulation. Am J Respir Cell Mol Biol. 1997;
9. Lallena MJ, Diaz-Meco MT, Bren G, et al. Activation of IkappaB kinase beta by protein kinase C isoforms. Mol Cell Biol. 1999;
10. Page K, Li J, Zhou L, et al. Regulation of airway epithelial cell NF-kappa B-dependent gene expression by protein kinase C delta. J Immunol. 2003;
11. Zhang QY, Hammerberg C, Baldassare JJ, et al. Retinoic acid and phorbol ester synergistically up-regulate IL-8 expression and specifically modulate protein kinase C-epsilon in human skin fibroblasts. J Immunol. 1992;
12. Meier RW, Niklaus G, Dewald B, et al. Inhibition of the arachidonic acid pathway prevents induction of IL-8 mRNA by phorbol ester and changes the release of IL-8 from HL 60 cells: differential inhibition of induced expression of IL-8, TNF-alpha, IL-1 alpha, and IL-1 beta. J Cell Physiol. 1995;
13. Keelan JA, Sato T, Mitchell MD. Regulation of interleukin (IL)-6 and IL-8 production in an amnion-derived cell line by cytokines, growth factors, glucocorticoids, and phorbol esters. Am J Reprod Immunol. 1997;
14. Shen F, Chen SJ, Dong XJ, et al. Suppression of IL-8 gene transcription by resveratrol in phorbol ester treated human monocytic cells. J Asian Nat Prod Res. 2003;
15. Kwon OJ, Au BT, Collins PD, et al. Tumour necrosis factor-induced interleukin-8 expression in cultured human airway cells. Am J Physiol. 2003;
16. Newton R, Hart LA, Stevens DA, et al. Effect of dexamethasone on IL-1 beta-induced NF-kappa B and kappa B-dependent transcription in epithelial cells. Eur J Biochem. 1998;
17. Tsang KW, Ho PL, Lam WK, et al. Inhaled fluticasone reduces sputum inflammatory indices in severe bronchiectasis. Am J Respir Crit Care Med. 1998;
18. Knight M, Hartman PE, Hartman Z, et al. A new method of preparation of pyocyanin and demonstration of an unusual bacterial sensitivity. Anal Biochem. 1979;
19. Ras GJ, Anderson R, Taylor GW, et al. Proinflammatory interactions of pyocyanin and 1-hydroxyphenazine with human neutrophils in vitro. J Infect Dis. 1990;
20. Bergmann M, Barnes PJ, Newton R. Molecular regulation of granulocyte macrophage colony-stimulating factor in human lung epithelial cells by interleukin (IL)-1β, IL-4, and IL-13 involves both transcriptional and post-transcriptional mechanisms. Am J Respir Cell Mol Biol. 2000;
21. Look DC, Stoll LL, Romig SA, et al. Pyocyanin and its precursor phenazine-1-carboxylic acid increase IL-8 and intercellular adhesion molecule-1 expression in human airway epithelial cells by oxidant-dependent mechanisms. J Immunol. 2005;
22. Reibman J, Talbot AT, Hsu Y, et al. Regulation of expression of granulocyte-macrophage colony-stimulating factor in human bronchial epithelial cells: roles of protein kinase C and mitogen-activated protein kinases. J Immunol. 2000;
23. Wertheim WA, Kunkel SL, Standiford TJ, et al. Regulation of neutrophil-derived IL-8: the role of prostaglandin E2, dexamethasone, and IL-4. J Immunol. 1993;
24. Lippert U, Kruger-Krasagakes S, Moller A, et al. Pharmacological modulation of IL-6 and IL-8 secretion by the H1-antagonist decarboethoxy-loratadine and dexamethasone by human mast and basophilic cell lines. Exp Dermatol. 1995;
25. Nyhlen K, Linden M, Andersson R, et al. Corticosteroids and interferons inhibit cytokine-induced production of IL-8 by human endothelial cells. Cytokine. 2000;
26. Dubois EFL. Clinical potencies of glucocorticoids: what do we really measure?. Curr Respir Med Rev. 2005;
27. Zheng L, Shum H, Tipoe GL, et al. Macrophages, neutrophils and tumour necrosis factor-α expression in bronchiectatic airways in vivo. Respir Med. 2001;
28. Ho JC, Tipoe G, Zheng L, et al. In vitro study of regulation of IL-6 production in bronchiectasis. Respir Med. 2004;
29. Tsang KW, Tipoe GL. Bronchiectasis: not an orphan disease in the East. Int J Tuberc Lung Dis. 2004;
30. Sorensen RU, Klinger JD, Cash HA, et al. In vitro inhibition of lymphocyte proliferation by Pseudomonas aeruginosa phenazine pigments. Infect Immun. 1983;
31. Tsang KW, Chan K, Ho P, et al. Sputum elastase in steady-state bronchiectasis. Chest. 2000;
32. Zheng L, Lam WK, Tipoe GL, et al. Overexpression of matrix metalloproteinase-8 and -9 in bronchiectatic airways in vivo. Eur Respir J. 2002;
33. Tsang KW, Tan KC, Ho PL, et al. Inhaled fluticasone in bronchiectasis: a 12-month study. Thorax. 2005;